LINC01929

Across TCGA pan-cancer cohorts, LINC01929 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of LINC01929’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01929 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01929 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

KIRC, HNSC, and BLCA are the cancer types where LINC01929 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01929 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.929	<.001	12	view →
HNSC	All	IV	+0.972	<.001	11	view →
BLCA	All	III,IV	+0.430	<.001	11	view →
KICH	All	III,IV	−0.210	.002	9	view →
LUAD	All	All	+0.578	<.001	7	view →
COAD	Male	II,III,IV	+0.321	<.001	7	view →
BRCA	All	II,III,IV	+1.329	<.001	6	view →
STAD	Male	All	+0.136	<.001	6	view →
LIHC	Female	II,III,IV	+0.058	<.001	6	view →
LUSC	Male	All	+0.751	<.001	5	view →
READ	All	III,IV	+0.474	.021	2	view →
CHOL	All	All	+0.167	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

LINC01929–KIRC

Open the KIRC breakdown →